Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07441642 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Secondary endpoints: details revised at 5 of 11 entries
MinorTrial sites expanded: 51 → 55 locationsv18
NotablePrimary endpoint(s) modified
Secondary endpoints revised (11)
Site details revised at 12 of 51 sites
Eligibility criteria shortened, about 1 word
v17
MinorTrial sites expanded: 41 → 51 locationsv16
MinorTrial sites expanded: 38 → 41 locationsv15
MinorTrial sites expanded: 35 → 38 locationsv14
MinorTrial sites expanded: 28 → 35 locationsv13
MinorTrial sites expanded: 22 → 28 locations
Site contacts updated at 1 of 28 sites
v12
MinorStudy sites: 22 to 28v11
MinorTrial sites expanded: 19 → 22 locationsv10
MinorTrial sites expanded: 16 → 19 locationsv9
MinorStudy sites: 14 to 16v8
MinorTrial sites expanded: 7 → 12 locationsv7
MinorStudy sites: 7 to 12v6
MinorStudy sites: 5 to 7v5
MinorStudy sites: 4 to 5v4
MinorStart date changed from estimate of Mar 30, 2026 to Mar 9, 2026v3
NotableTrial status: Not Yet Recruiting to Recruiting
Study sites: 0 to 4
v2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).